Literature DB >> 18466764

Immune-suppressive activity of punicalagin via inhibition of NFAT activation.

Sang-Ik Lee1, Byoung-Soo Kim, Kyoung-Shin Kim, Samkeun Lee, Kwang-Soo Shin, Jong-Soon Lim.   

Abstract

Since T cell activation is central to the development of autoimmune diseases, we screened a natural product library comprising 1400 samples of medicinal herbal extracts, to identify compounds that suppress T cell activity. Punicalagin (PCG) isolated from the fruit of Punica granatum was identified as a potent immune suppressant, based on its inhibitory action on the activation of the nuclear factor of activated T cells (NFAT). PCG downregulated the mRNA and soluble protein expression of interleukin-2 from anti-CD3/anti-CD28-stimulated murine splenic CD4+ T cells and suppressed mixed leukocytes reaction (MLR) without exhibiting cytotoxicity to the cells. In vivo, the PCG treatment inhibited phorbol 12-myristate 13-acetate (PMA)-induced chronic ear edema in mice and decreased CD3+ T cell infiltration of the inflamed tissue. These results suggest that PCG could be a potential candidate for the therapeutics of various immune pathologies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18466764     DOI: 10.1016/j.bbrc.2008.04.150

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Evaluation of the effect of Punica granatum juice and punicalagin on NFκB modulation in inflammatory bowel disease.

Authors:  Tanmay A Shah; Mihir Parikh; Kirti V Patel; Kalpana G Patel; Chaitanya G Joshi; Tejal R Gandhi
Journal:  Mol Cell Biochem       Date:  2016-06-28       Impact factor: 3.396

2.  Pomegranate inhibits neuroinflammation and amyloidogenesis in IL-1β-stimulated SK-N-SH cells.

Authors:  Ravikanth Velagapudi; Gina Baco; Sunjeet Khela; Uchechukwu Okorji; Olumayokun Olajide
Journal:  Eur J Nutr       Date:  2015-07-10       Impact factor: 5.614

3.  Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation.

Authors:  Shazaan Hushmendy; Lalithapriya Jayakumar; Amy B Hahn; Devang Bhoiwala; Dipti L Bhoiwala; Dana R Crawford
Journal:  Nutr Res       Date:  2009-08       Impact factor: 3.315

4.  Punicalagin attenuates osteoclast differentiation by impairing NFATc1 expression and blocking Akt- and JNK-dependent pathways.

Authors:  Mayumi Iwatake; Kuniaki Okamoto; Takashi Tanaka; Takayuki Tsukuba
Journal:  Mol Cell Biochem       Date:  2015-06-06       Impact factor: 3.396

5.  Pomegranate juice and punicalagin attenuate oxidative stress and apoptosis in human placenta and in human placental trophoblasts.

Authors:  Baosheng Chen; Methodius G Tuuli; Mark S Longtine; Joong Sik Shin; Russell Lawrence; Terrie Inder; D Michael Nelson
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-28       Impact factor: 4.310

6.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

7.  Punicalagin inhibits Salmonella virulence factors and has anti-quorum-sensing potential.

Authors:  Guanghui Li; Chunhong Yan; Yunfeng Xu; Yuqing Feng; Qian Wu; Xiaoying Lv; Baowei Yang; Xin Wang; Xiaodong Xia
Journal:  Appl Environ Microbiol       Date:  2014-08-01       Impact factor: 4.792

8.  Punicalagin inhibits inflammation in LPS-induced RAW264.7 macrophages via the suppression of TLR4-mediated MAPKs and NF-κB activation.

Authors:  Xiaolong Xu; Peng Yin; Changrong Wan; Xinlu Chong; Mingjiang Liu; Peng Cheng; Jiajia Chen; Fenghua Liu; Jianqin Xu
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

9.  Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease.

Authors:  Lalida Rojanathammanee; Kendra L Puig; Colin K Combs
Journal:  J Nutr       Date:  2013-03-06       Impact factor: 4.798

10.  Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?

Authors:  Matthias Sieber; Ria Baumgrass
Journal:  Cell Commun Signal       Date:  2009-10-27       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.